SCHEMBL30602777

SCHEMBL30602777

OC1(c2cc(Cl)cc3c2cnn3C2CCCCO2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RXRA P19793 1/20 0.41
▸ RXRB P28702 1/20 0.41
▸ RXRG P48443 1/20 0.41
▸ CYP4F2 P78329 2/20 0.36
▸ CYP4A11 Q02928 2/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ DGAT2 Q96PD7 1/20 0.36
▸ P2RX7 Q99572 2/20 0.32
▸ IL1B P01584 1/20 0.32
▸ ATR Q13535 5/20 0.31
▸ YTHDC1 Q96MU7 1/20 0.31
▸ PDE1A P54750 1/20 0.31
▸ PDE1B Q01064 1/20 0.31
▸ PDE1C Q14123 1/20 0.31
▸ PDE9A O76083 1/20 0.30
▸ RET P07949 1/20 0.30
▸ KRAS P01116 1/20 0.30
▸ IDH1 O75874 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20938994 1.00 RXRA (0.41) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL25413737 0.84 RXRA (0.44) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL20916885 0.81 RXRA (0.35) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL21196196 0.79 CYP4F2 (0.45) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL17731741 0.79 RXRA (0.42) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL30950246 0.79 CYP4F2 (0.45) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL29561854 0.79 RXRA (0.42) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL30959489 0.79 CYP4F2 (0.41) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL30959599 0.79 RXRA (0.39) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL30959248 0.79 RXRA (0.39) RXRARXRBRXRGCYP4F2CYP4A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111601808-B Heterocyclic compounds and compositions and methods of use thereof 捷思英达医药技术(上海)有限公司 2023-09-08 — — CN disclosed
Send feedback